FDA to speed nanomedical product creation
Posted on: Tuesday, 10 March 2009, 13:43 CDT
The U.S. Food and Drug Administration says it will collaborate with the Alliance for NanoHealth to speed creation of safe nanotechnology medical products.
The FDA said it and the alliance's member institutions will cooperate in a nanotechnology initiative to expand knowledge of how nanoparticles behave and affect biologic systems, and to facilitate the development of tests and processes that might mitigate the risks associated with nanoengineered products.
FDA's nanotechnology initiative with the Alliance for NanoHealth is an effort to engage resources and technical expertise in this rapidly advancing field and is a clear example of leveraging science and scientists to advance the public good,
said the FDA's Acting Commissioner, Dr. Frank Torti. Nanotechnology holds great promise for the advancement of novel medical products.
The alliance's eight academic institutions are the Baylor College of Medicine, the University of Texas' M.D. Anderson Cancer Center, Rice University, the University of Houston, the University of Texas Health Science Center at Houston, Texas A & M Health Science Center, the University of Texas Medical Branch at Galveston and the Methodist Hospital Research Institute in Houston.
Source: United Press International
Related Articles
- WaferGen Announces that University of Texas Southwestern Medical Center Demonstrates Utility of New SmartChip(TM) Nano-Dispenser with WaferGen's SmartChip(TM) High-throughput Real-Time PCR System
- Solos Endoscopy, Inc. Receives Purchase Orders from University of California, San Diego Medical Center for its MammoView(TM) Product Line
- Creighton University, St. Joseph's Hospital and Medical Center Announce New School of Medicine Campus in Phoenix
- WaferGen Biosystems, ImmuneRegen BioSciences and University of Texas Southwestern Medical Center to Collaborate on Novel Wound Healing Research
- WaferGen and University of Texas Southwestern Medical Center Establish Biomarker Research Collaboration for SmartChip(TM) Real-Time PCR System
- University of California San Diego Medical Center Selects MediServe for a Complete Respiratory Care Solution
- AstraZeneca Opens Its First Clinical Pharmacology Unit in the U.S. At the University of Pennsylvania's Penn Presbyterian Medical Center
- Alnylam Announces Collaboration With University of Texas Southwestern Medical Center to Discover RNAi Therapeutics for Hypercholesterolemia; Collaboration to Focus on PCSK9, a Key Gene Involved in Metabolism of LDL-Cholesterol
- Daxor Announces University of California, San Diego Medical Center Acquires Blood Volume Analyzer BVA-100
- Galveston, Texas, Academic Medical Center Gets Funds to Build Biodefense Lab
 |
 |
User Comments (0)
RSS Feeds